返回 Agenda
T1S5: Strategic Role of RWE in Evidence Planning
Session Chair(s)
Shruti MP, MSC
Director-Real World Data Solutions
Parexel International, India
As the demand for robust, patient-centered data grows, RWE is becoming a critical component in shaping regulatory, market access, and clinical decisions. The sessions will cover best practices, evolving methodologies, and the future landscape of RWE in driving more informed and impactful evidence strategies.
Speaker(s)
Role of RWE In Evidence-Based Medicine
Amrita Ostawal
Arete Access, India
Managing Director
Integrated Evidence Generation Plans- Bridging Clinical Trials, RWE and Market Access
Sriram Govindan
Eli Lilly Services India Private Limited, India
Associate Director-Publications, Global Scientific Communications
With the Additional Presence of
Ambika Subramanian
NTT Data, India
Head Medical Writing, Life Sciences Consulting
With the Additional Presence of
Alben Sigamani
Carmel Research Consultancy Pvt. Ltd., India
Director & Founding Professor